The Value of Serum MicroRNA Expression Signature in Predicting Refractoriness to Bortezomib-Based Therapy in Multiple Myeloma Patients
scientific article published on 09 September 2020
Author/s
author: Dariusz Jarych, Damian Mikulski, Konrad Stawiski, Tadeusz Robak, Piotr Smolewski, Wojciech Fendler, Janusz Szemraj, Małgorzata Misiewicz, Pawel Robak, Edyta Węgłowska, Izabela Drozdz
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.